Comparison of patient characteristics between those who developed stroke within 90 days of last treatment and all controls, that is, stroke patients without previous anti‐VEGF treatment, showed no difference in presence of hypertension (measured as using antihypertensive medicines), atrial fibrillation, a previous TIA or reported smoking (Table 4). This evidence concerns the gene VEGFA and Stroke.